Medigro Pharmaceutical Private Limited
About Medigro Pharmaceutical Private Limited
Data last updated:
Medigro Pharmaceutical Private Limited is a private limited company based in Om Sakthi Nagar, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 May 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24304TN2020PTC135483.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Pradeep and Sridhar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 116 Second Floor, Om Sakthi Nagar, Tamil Nadu, India – 605102.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.34 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹13,189 (net margin 1.6%) and EBITDA of ₹13,189 (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years.
Company details
Contact details
Medigro Pharmaceutical Private Limited's registered office is in Om Sakthi Nagar, Tamil Nadu.
- Registered AddressNo 116 Second Floor, Om Sakthi Nagar, Tamil Nadu, India – 605102
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medigro Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medigro Pharmaceutical Private Limited, buy the company report.
Financials of Medigro Pharmaceutical Private Limited
FY 2025 filings availableMedigro Pharmaceutical Private Limited reported revenue of ₹8.34 Lakh (down 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 18% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹13,189 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹13,189 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.6% | |||
| Net Profit Margin | 1.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medigro Pharmaceutical Private Limited, buy the company report.
Board of directors of Medigro Pharmaceutical Private Limited
Medigro Pharmaceutical has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradeep Also directs: Aucklane Life Science Private Limited, Heamcure Pharmaceuticals Private Limited, Guruv Pharmaceutical Private Limited and 1 more | Director | 31 May 2020 | 6 Years 5 Months | Current |
| Sridhar Also directs: Aucklane Life Science Private Limited | Director | 11 Dec 2025 | 0 Years 11 Months | Current |
Peer comparison
Medigro Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Catafast Construction Chemicals Private Limited | ₹8.38 Lakh (FY 2025) | -41.0% | Naranapur, Odisha, India | |||
| Well Being Bio-Science Private Limited | ₹8.37 Lakh (FY 2017) | Chennai, Tamil Nadu, India | ||||
| Corley Polymers Private Limited | ₹8.37 Lakh (FY 2025) | -39.0% | Udaipur, Rajasthan, India | |||
| Hedonista Private Limited | ₹8.35 Lakh (FY 2019) | -70.0% | New Delhi, Delhi, India | |||
| Vedya Pharmaceuticals Private Limited | ₹8.35 Lakh (FY 2021) | 4.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Medigro Pharmaceutical Private Limitedthis company | ₹8.34 Lakh (FY 2024) | ₹13,189 | 1.6% | -18.0% | Om Sakthi Nagar, Tamil Nadu, India | |
| Huemills India Private Limited | ₹8.33 Lakh (FY 2023) | 128.0% | Palakkad, Kerala, India | |||
| Hugge Healthcare Private Limited | ₹8.3 Lakh (FY 2023) | Thiruvananthapuram, Kerala, India | ||||
| Benzyl Pharmaceuticals Private Limited | ₹8.3 Lakh (FY 2024) | 32.0% | Lucknow, Uttar Pradesh, India | |||
| Richmond Biosciences Private Limited | ₹8.29 Lakh (FY 2022) | -69.0% | Secunderabad, Telangana, India | |||
| Salcreat Manufacturing Private Limited | ₹8.27 Lakh (FY 2025) | -7.0% | Delhi, India |
To see the full peer comparison of Medigro Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medigro Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medigro Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medigro Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medigro Pharmaceutical Private Limited has 7 board changes on record since 2020: 3 appointments and 4 cessations. The latest: Sridhar was appointed as Director on 11 Dec 2025.
Frequently asked questions
Medigro Pharmaceutical is an active private limited company based in Om Sakthi Nagar, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 May 2020 (6+ years old) and is registered under CIN U24304TN2020PTC135483.
The latest financial statements of Medigro Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Medigro Pharmaceutical is U24304TN2020PTC135483. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medigro Pharmaceutical was incorporated on 31 May 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Medigro Pharmaceutical by revenue are Catafast Construction Chemicals Private Limited, Well Being Bio-Science Private Limited, Corley Polymers Private Limited, Hedonista Private Limited, Vedya Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sridhar was appointed as Director on 11 Dec 2025. Ekambaram Vignesh Kumar was appointed as Director on 07 Jun 2025. Sujitha ceased to be Director on 07 Jun 2025. Medigro Pharmaceutical has 7 board changes on record in total.
The registered office of Medigro Pharmaceutical is at No 116 Second Floor, Om Sakthi Nagar, Tamil Nadu, India – 605102.
Medigro Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Medigro Pharmaceutical can be reached at its registered office: No 116 Second Floor, Om Sakthi Nagar, Tamil Nadu, India – 605102.
Medigro Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
